Today (April 20), the daily report of A-share listed companies mainly includes: Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) intraday limit approaching Sungrow Power Supply Co.Ltd(300274) fell into hot search; The market value of “ningwang” fell below trillion; St Changdong received the decision of Shenzhen Stock Exchange to terminate the listing of the company’s shares; If the acquisition is not clear, the share price rises by the limit first, Inzone Group Co.Ltd(600858) denies the disclosure of information, etc
hot company trends:
{{{{{{{{{{{{123
Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) ( Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) ) fell sharply on the 20th, once approaching the limit. Since the beginning of this year, the stock price of Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) s has had a strong trend, hitting a record high of 43.12 yuan in April 12 (after the resumption of rights). As of the closing on April 14, the cumulative increase of the stock has doubled. However, on April 15 and 18, the stock fell by the limit for two consecutive days.
Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) 20 said in response to investors’ questions on the interactive platform that “the research and development process of Lianhua Qingwen is only 15 days” reported in the media article is inconsistent with the facts. Lianhua Qingwen is an innovative application of collateral disease theory to epidemic prevention and control. The founder of the company has been committed to collateral disease research for 40 years. He has built a collateral disease theoretical system for the first time in the history of the development of traditional Chinese medicine and established a new discipline of collateral disease of traditional Chinese medicine. The leader of the company’s scientific research team has applied collateral disease theory to lung diseases for the first time, discussed the occurrence and development law of pulmonary collateral diseases, and gathered three famous prescriptions for the prevention and control of epidemic diseases of traditional Chinese medicine for 2000 to become the prescription of Lianhua Qingwen, And add Patchouli fragrance to protect the spleen and stomach and Rhodiola to improve immunity and healthy qi. The innovative research of compound Chinese medicine requires the inheritance of the essence of Chinese medicine and the complete process of “theoretical innovation clinical practice pre clinical research clinical research new drug approval”.
Ge Lan, Liu Yanchun, Li Xiaoxing and other famous generals are listed
Shortly after the opening, it was close to the limit line. Sungrow Power Supply Co.Ltd(300274) boarded the microblog hot search this morning. At the same time, Contemporary Amperex Technology Co.Limited(300750) , Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) and other shocks went down. This has greatly injured many public funds Sungrow Power Supply Co.Ltd(300274) the main reason for today’s sharp decline is that the latest disclosed performance is lower than the market expectation. According to the annual report, last year’s revenue was about 24.137 billion yuan, a year-on-year increase of 25.15%; The net profit attributable to shareholders of listed companies was 1.583 billion yuan, a year-on-year decrease of 19.01%. In addition, the company’s revenue in the first quarter of 2022 was about 4.568 billion yuan, a year-on-year increase of 36.48%; The net profit was about 411 million yuan, a year-on-year increase of 6.26%.
With the announcement of the first quarterly report, the position changes of Sungrow Power Supply Co.Ltd(300274) some of the top ten circulating shareholders surfaced. By the end of the first quarter of this year, GF high-end manufacturing managed by Zheng chengran had been listed as the fourth largest circulating shareholder of Sungrow Power Supply Co.Ltd(300274) with 13245600 shares, an increase of 876600 shares compared with 12369000 shares at the end of 2021.
“ningwang” market value fell below trillion hit a new low in adjustment! Consumer stocks rose collectively what happened
Contemporary Amperex Technology Co.Limited(300750) ( Contemporary Amperex Technology Co.Limited(300750) ) opened low and went low on the 20th, with a sharp intraday drop of more than 7%. The stock price hit a new low in this round of adjustment, and the market value fell below the trillion mark. The annual performance forecast for 2021 disclosed by the company on January 28 shows that the net profit attributable to the shareholders of the listed company in 2021 is expected to be 14-16.5 billion yuan, with a year-on-year increase of 150.75% – 195.52%; The company said that the increase in performance in 2021 compared with the same period of last year was mainly due to the increase in the market penetration of new energy vehicles and energy storage in 2021, which led to the growth of battery sales; The company has made progress in market development, released new production capacity and increased production and sales accordingly; The company strengthened cost control and reduced the proportion of expenses in revenue. The company’s annual report will be officially disclosed on April 22.
At that time, Soochow Securities Co.Ltd(601555) pointed out that the company’s stock price was wrongly killed due to various rumors recently, and the valuation was corrected to the bottom of history. 2022 is a big year for the global sales of electric vehicles and energy storage, and the company has sufficient orders. It is expected that the global share will further increase to 35% +, and the shipment volume and performance are expected to continue to double. The current valuation is obviously underestimated. Considering the high growth of the company in 2022 and the global power battery longyi, the customer, technology and cost are all in the lead, and the long-term advantages are prominent, the company is given a certain valuation premium, 70 times PE in 2022, and the target price is 905.8 yuan.
Citic Securities Company Limited(600030) also said that the company’s fundamentals are still strong. In terms of market share, the company’s global and Chinese market share in 2021 were 32.6% and 52.4% respectively. It has maintained the first position in the world for five consecutive years, and the leading position is expected to be maintained. It is estimated that in 2022, the sales volume of new energy vehicles in China / around the world will be 5.5 million and 9.62 million respectively, and the corresponding power battery demand will be 286gwh and 500gwh respectively. Superimposed on the rapidly growing demand of the energy storage industry, the demand side of the industry will remain strong, the company’s capacity will be released rapidly, and the breakthrough of overseas power batteries and energy storage batteries is expected to be accelerated. In the field of technology, the company has successively released structural innovative technologies such as CTP, CTC and a + B, as well as new technical solutions such as sodium ion battery and power exchange, so as to continue to lead the development of the industry.
terminate listing! Once wanted to build “Oriental Disney” now losing money for years the stock price is only 1.03 yuan
On the evening of April 19, Great Wall International Acg Co.Ltd(000835) announced that the company received the decision of Shenzhen Stock Exchange to terminate the listing of the company’s shares, and the company’s shares will enter the delisting and consolidation period from April 27. On the trading day next to the expiration of the delisting and consolidation period, the company’s shares will be delisted and terminated from listing.
As of March 24, Great Wall International Acg Co.Ltd(000835) share price was 103 yuan, and the market value was only 337 million yuan. In just a few years, the original dream of building “Oriental Disney” has been broken, which is very sad.
According to the announcement, Great Wall International Acg Co.Ltd(000835) received the decision on terminating the listing of Great Wall International Acg Co.Ltd(000835) shares from Shenzhen Stock Exchange on April 19, and Shenzhen Stock Exchange decided to terminate the listing of the company’s shares.
the acquisition is not clear, and the share price rises by the limit first Inzone Group Co.Ltd(600858) deny the disclosure of information
On April 15, April 18 and April 19, Inzone Group Co.Ltd(600858) closed at the limit for three consecutive trading days. According to the announcement issued by the company on April 19, Inzone Group Co.Ltd(600858) is planning to acquire 100% equity of Rizhao Ginza, retail business of Jinan Ginza Qilishan branch and 100% equity of Ginza electric appliance.
According to the after hours data released by Shanghai Stock Exchange, during the three consecutive trading periods of Inzone Group Co.Ltd(600858) trading, in addition to Changjiang Securities Company Limited(000783) Shanghai Dongming Road Securities Business Department and Haitong Securities Company Limited(600837) Jinan Hongjialou South Road Securities Business Department, well-known hot money elder brother Zhao also appeared on the Dragon Tiger list.
In the announcement of stock price changes, Inzone Group Co.Ltd(600858) said that in addition to planning to acquire the assets of the controlling shareholder, the company, the controlling shareholder and the actual controller had no other major matters affecting the abnormal fluctuation of the company’s stock trading. The company has not found any media reports or market rumors that may have a significant impact on the company’s stock trading price, and has not found any other major events that may have a significant impact on the company’s stock price
institutions recently rush to raise these 46 shares
Statistics show that among the dragon and tiger lists in the past five trading days, 104 stocks appeared in the figure of institutions, of which 46 stocks were net purchases and 58 stocks were net sales. The top three institutions in net purchases in the past five days are Andon Health Co.Ltd(002432) , Bethel Automotive Safety Systems Co.Ltd(603596) , Shandong Haihua Co.Ltd(000822) , with net institutional capital inflows of 489 million yuan, 164 million yuan and 92 million yuan respectively. In addition, the top stocks sold by institutions are Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) , Hainan Poly Pharm.Co.Ltd(300630) , Shanxi Coking Coal Energy Group Co.Ltd(000983) etc. the net outflow of institutional funds is 514 million yuan, 349 million yuan and 240 million yuan respectively.
86 companies awarded institutional research (list attached)
Statistics show that in the past five trading days (from April 13 to April 19), about 86 companies in the two cities have been investigated by institutions. The type of research institutions shows that securities companies have investigated 74 companies, that is, 86.05% of the research activities of listed companies have been participated by securities companies; 70 fund companies were surveyed, ranking second; 55 insurance companies were surveyed, ranking third.
In the institutional research list, a total of 39 companies were investigated by more than 20 institutions Hangzhou Hikvision Digital Technology Co.Ltd(002415) has attracted the most attention, with 367 institutions participating in the research Guangzhou Tinci Materials Technology Co.Ltd(002709) was surveyed by 256 institutions, ranking second in the list Inspur Electronic Information Industry Co.Ltd(000977) , Chengdu Wintrue Holding Co.Ltd(002539) and others were investigated by 176 and 175 institutions respectively.
online research becomes the mainstream! What do Zhu Shaoxing, Fu Pengbo and Feng Mingyuan focus on the exposure of star fund managers
Recently, the research of public funds is mainly online. Data show that between March 1 and April 16 this year, 39 public fund companies conducted more than 100 investigations, including 226 investigations of Harvest Fund, and more than 150 investigations of Wells Fargo fund, Huaxia Fund, Nanfang fund, GF fund, Boshi fund and huitianfu fund.
In the same period last year, only 10 public funds have been investigated more than 100 times, of which Harvest Fund has a total of 150 times. The other 9 include Huaxia Fund, Wells Fargo fund, China Europe Fund, South Fund, Bank of communications Schroeder fund, ICBC Credit Suisse fund, GF fund, China Merchants fund and Celestica fund.
ten billion private placement positions surfaced in the first quarter optimistic about the opportunity of dilemma reversal
With the disclosure of the first quarterly report of listed companies, the positions of many well-known 10 billion private placement companies such as Gaoyi assets, Panjing investment and yuanlesheng have surfaced. From the exposed positions, the dilemma reversal opportunities of medicine, automobile, consumption and other sectors have attracted much attention Zhejiang Gongdong Medical Technology Co.Ltd(605369) recently disclosed the first quarterly report. As of the end of March this year, the list of the top ten circulating shareholders of Panjing investment’s new products was 568000 shares; The China EU medical and health mixed fund managed by the well-known public fund manager Glenn has increased its position by 1.774 million shares. At the same time, the products of private placement source Lesheng also appeared in the list of Zhejiang Gongdong Medical Technology Co.Ltd(605369) top ten circulating shareholders. The number of shares held at the end of the first quarter was 597000 shares, unchanged from that at the end of last year.
